To the central content area :::
ECO-Fin
:::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

6589 EirGenix
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Lee-Cheng Liu Lee-Cheng Liu Lee-Cheng Liu (02)7708-0123 No.101, Lane 169, Kangning St., Xizhi Dist.New Taipei City 22180, Taiwan (R.O.C.) 2019/06/28
Industry Main Business
Biotechnology and Medical Care EirGenix operates two business units, a CDMO unit providing biopharmaceutical contract development and manufacturing services and a product unit developing high quality and affordable biosimilars to the benefits of patients around the global. EirGenix is committed to providing client-centric products and services to ensure our customers achieve their business goals.Our dedicated team of professionals work closely with our clients to ensure that our clients receive the highest-quality products and services that are both timely and cost-effective. By striving to be a responsible and reliable service provider, we hope to build lasting and mutually-productive partnerships with our clients.
 
Market Information ( 2024/04/18 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
365.911 81.00  79.80  80.60  -0.70  710 .11 7,918 47
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2024/04/18)
TPEx measures
adopted
(2024/04/18)
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.